Clinical trials
Phase 1 Gastrointestinal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 11 |
| Terminated | 6 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| Revolution Medicines, Inc. | 4 |
| Boehringer Ingelheim | 3 |
| M.D. Anderson Cancer Center | 2 |
| Poniard Pharmaceuticals | 2 |
| University of Utah | 2 |
| Bristol-Myers Squibb | 1 |
| Celldex Therapeutics | 1 |
| Curegenix Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 56 |
| Colorectal Neoplasms | 20 |
| Pancreatic Neoplasms | 17 |
| Neoplasms | 14 |
| Breast Neoplasms | 13 |
| Lung Neoplasms | 12 |
| Ovarian Neoplasms | 12 |
| Colonic Neoplasms | 10 |
| Head and Neck Neoplasms | 10 |
| Stomach Neoplasms | 10 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.